Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-10-30 to 2024-10-31
Current total value of award: $6577.07
Description: 4566275641!QUILLIVANT XR ORAL SUSP 60ML 5MG/ML